Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
- A versatile range
of products
- A unique lifting
capacity
- A safe procedure
- Intended for skilled
doctors
- Unique advantages for
both doctor and patients
Packed in 5
pixL
NEW &
PATENT
ED!
HYALUROSTRUCTU
RE
pixL +
Cannula description
Manufactured by Thiebaud SAS in France
Made of surgical grade stainless steel
Made in one continuous piece with a polished surface
Anti-coring treatment to avoid damage of tissue during insertion
Blunt tip
Exit hole (orifice) is:
Smooth design to avoid damage of the tissue
Allowing the gel to flow easily through the cannula
Close-up
Arrow
marking
orifice up
or down
Blunt tip
Orifice (opening)
Special design of hub
enabling Restylane products
to flow easier
firmly attached to the syringe
Customer Benefits
Unique advantages for the physician
Highly precise result
due to a good regulation of flow rate
special internal properties and base allows easy injection of
the product
Easy insertion in the tissue
due to improved mechanical resistance with high flexibility
Limited occurrence of hematomas and bruising
due to the profile of the tip
Easy handling
Consumer benefits
SUMMARY
PixL Microcannulas
Bullet blunt tip
& Polished glass
Continuous orifice
Other
Microcannulas
breakage
Standard base designed for
High resistance to HA
causing expulsion risk
Needles
No signals
Blind injection
Background
Two techniques developed in 2009 with Thiebaud
microcannulas:
Dr. Dreissigacker PS Germany:
Individual Face Balance
Dr. Berros OCPS Monaco:
Hyalurostructure
pixL treatments
pixL + treatments
Oculofacial treatments
Ex. Dr. Berros treatment: Hyalostructure
"Dreissigacker model"
Injection points
pixL +
Specially designed for periorbital use avoiding tissue
traumatism in such a fragile area
Reinforced at the base to limit the flexibility
Patented no other available on the market!
Clinical references about safety, efficiency and patient
satisfaction
Available microcannulas
28G, 40 mm length
25G, 40 mm length
Clinical Data
Hyalurostructure: how to avoid complications when filling the
periorbital area in the treatment of tear
through. Ph. Berros.
Beausoleil, CHPG,
Monaco. J. Md. Esth. Et Chir. Derm. Vol XXXVI,
144, Dcembre 2009, 189 192.
Objective:
Study how to avoid complications when filling the periorbital area in the
treatment of tear through as those complications limit the development of
this technique.
Methods:
Conclusion:
Significant improvement
of eyetrough comparing to
Clinical Data
Periorbital contour abnormalities: hollow eye ring management
with hyalurostructure. Berros P.
Ophthalmologist, Oculoplasty,
France, CHPG, Monaco. Orbit.
2010 Apr; 29(2):119-25.
Objective:
Study a new technique for treating periorbital hollowing with hyaluronic gel filling using a unique cannula designed specifically for periorbital use.
Methods:
26 patients involved.
0.8 to 1 cc of Hyaluronic Acid injected in both sides.
Analysis of patients just after the injection, in 10 to 25 days and 3 months
after the treatment.
Results: